Aranorosin circumvents arbekacin-resistance in MRSA by inhibiting the bifunctional enzyme AAC(6′)/APH(2)

Journal of Antibiotics

Volumn 65, Issue 10, 2012, Pages 527-529

  Suga, Takuya ^a   Ishii, Takahiro ^a   Iwatsuki, Masato ^a   Yamamoto, Tsuyoshi ^a   Nonaka, Kenichi ^a   Masuma, Rokuro ^a   Matsui, Hidehito ^a   Hanaki, Hideaki ^a   O'mura, Satoshi ^a   Shiomi, Kazuro ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

arbekacin resistant; circumvention; daranorosin; MRSA

Indexed keywords

ARANOROSIN; HABEKACIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL;

ACETYLTRANSFERASES; ANTI-BACTERIAL AGENTS; DIBEKACIN; DRUG RESISTANCE, BACTERIAL; ENZYME INHIBITORS; FURANS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR);

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 84868115042     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2012.53     Document Type: Article

References (18)

1. Tomasz, A. Multiple-Antibiotic resistant pathogenic bacteria. N. Engl. J. Med. 330,1247-1251 (1994
2. Kondo, S., Iinuma, K., Yamamoto, H., Maeda, K. & Umezawa, H. Syntheses of 1-N- {(S)-4-Amino-2-hydroxybutyryl}-kanamycin B and -3',4'-dideoxykanamycin B active against kanamycin-resistant bacteria. J. Antibiot. 26, 412-415 (1973
3. Kondo, S. & Hotta, K. Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications. J. Infect. Chemother. 5, 1-9 (1999
4. Tabata, M., Shimizu, M., Araake, M. & Ogawa, H. Relationship between arbekacinsusceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA). Jpn. J. Antibiot. 56, 36-43 (2004
5. Tsuchizaki, N. et al. Trends of arbekacin-resistant MRSA strains in Japanese hospitals (1979 to 2000). J. Antibiot. 59, 229-233 (2006
6. Kondo, S. et al. Structures of enzymatically modified products of arbekacin by methicillin-resistant Staphylococcus aureus. J. Antibiot. 46, 310-315 (1993
7. Iwatsuki, M. et al. Biverlactones A-D, new circumventors of arbekacin resistance in MRSA, produced by Penicillium sp. FKI-4429. Tetrahedron 67, 6644-6648 (2011
8. Roy, K. et al. Aranorosin, a novel antibiotic from Pseudoarachiniotus roseus. I. Taxonomy, fermentation, isolation, chemical and biological properties. J. Antibiot. 41, 1780-1784 (1988
9. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 8th edn. CLSI document M7-A8CLSI, Wayne, Pennsylvania (2009
10. Yamamoto, T. et al. Antimicrob. Agents Chemother., In preparation
11. Kondo, S., Iinuma, K., Yamamoto, H., Ikeda, Y. & Maeda, K. Synthesis of (S)-4-Amino- 2-hydroxybutyryl derivatives of 3',4'-dideoxykanamycin B and their antibacterial activities. J. Antibiot. 26, 705-707 (1973
12. Niijima, T. New antimicrobial agent series XL: Arbekacin. Jpn. J. Antibiot. 44, 705-717 (1991
13. Suzuki, T., Fujita, K., Nagamachi, N. & Ookubo, T. Emergence of arbekacin resistant strains among methicillin-resistant Staphylococcus aureus. Jpn. J. Antibiot. 47, 634-639 (1994
14. Udou, T. Functional characterization of a multiple-Antibiotic resistant plasmid from clinical isolates of methicillin-resistant Staphylococcus aureus. Kansenshogaku Zasshi 75, 382-389 (2001
15. Hotta, K., Sunada, A., Ikeda, Y. & Kondo, S. Double stage activity in aminoglycoside antibiotics. J. Antibiot. 53, 1168-1174 (2000
16. Hashimoto, H., Inoue, M. & Hayashi, I. Wide area survey of type and drug sensitivity of Staphylococcus aureus in Japan in 1992 and 1993. Jpn. J. Antibiot. 47, 618-626 (1993
17. Suzuki, T. High resistance mechanisms of methicillin-resistant Staphylococcus aureus to arbekacin. Jpn. J. Chemother. 44, 129-135 (1996
18. Ishino, K., Ishikawa, J., Ikeda, Y. & Hotta, K. Characterization of a bifunctional aminoglycoside-modifying enzyme with novel substrate specificity and its gene from a clinical isolate of methicillin-resistant Staphylococcus aureus with high arbekacin resistance. J. Antibiot. 57, 679-686 (2004